Review on the Burden of Episodic Migraine and Utilization of Patient Reported Outcome Measures.

IF 4.8 2区 医学 Q1 CLINICAL NEUROLOGY Current Neurology and Neuroscience Reports Pub Date : 2024-12-01 Epub Date: 2024-09-25 DOI:10.1007/s11910-024-01379-2
Mohammad Ismail Ehsani-Nia, Avi Wannon, Jessica Ailani
{"title":"Review on the Burden of Episodic Migraine and Utilization of Patient Reported Outcome Measures.","authors":"Mohammad Ismail Ehsani-Nia, Avi Wannon, Jessica Ailani","doi":"10.1007/s11910-024-01379-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>Migraine affects a large portion of the world's population. Migraine encompasses a broad range of symptoms, with broad reaching ramifications in the form of Health-Related Quality of Life (HRQoL) factors. In our review we sought to understand the aspects encompassing the burden of disease on both an individual and population level. Furthermore, we reviewed the development and incorporation of Patient Reported Outcome Measures (PROM), questionnaires that assess HRQoL in real time, in how they have been incorporated in clinical research up to now and how they can be utilized in clinical practice moving forward.</p><p><strong>Recent findings: </strong>It has been shown that there is much heterogeneity within the field in PROM development processes as well as their utilization in episodic migraine (EM) clinical trials. Furthermore, they are inconsistently used in clinical practice. Among the most commonly used PROMs, the MSQv2.1 is among the most valid and reliable. Beyond that, it also shows promise to help in guidance of clinical management of migraine.</p>","PeriodicalId":10831,"journal":{"name":"Current Neurology and Neuroscience Reports","volume":" ","pages":"665-670"},"PeriodicalIF":4.8000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Neurology and Neuroscience Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11910-024-01379-2","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/25 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of review: Migraine affects a large portion of the world's population. Migraine encompasses a broad range of symptoms, with broad reaching ramifications in the form of Health-Related Quality of Life (HRQoL) factors. In our review we sought to understand the aspects encompassing the burden of disease on both an individual and population level. Furthermore, we reviewed the development and incorporation of Patient Reported Outcome Measures (PROM), questionnaires that assess HRQoL in real time, in how they have been incorporated in clinical research up to now and how they can be utilized in clinical practice moving forward.

Recent findings: It has been shown that there is much heterogeneity within the field in PROM development processes as well as their utilization in episodic migraine (EM) clinical trials. Furthermore, they are inconsistently used in clinical practice. Among the most commonly used PROMs, the MSQv2.1 is among the most valid and reliable. Beyond that, it also shows promise to help in guidance of clinical management of migraine.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
关于发作性偏头痛的负担和患者报告结果测量法使用情况的综述。
审查目的:偏头痛影响着全球大部分人口。偏头痛的症状范围广泛,与健康相关的生活质量(HRQoL)因素影响深远。在我们的综述中,我们试图了解包括个人和人群疾病负担的各个方面。此外,我们还回顾了实时评估 HRQoL 的问卷调查 "患者报告结果测量法"(PROM)的发展和应用情况,以及迄今为止如何将其应用于临床研究和临床实践中:最新研究结果:研究表明,PROM 的开发过程以及在发作性偏头痛(EM)临床试验中的应用存在很大差异。此外,它们在临床实践中的使用也不一致。在最常用的PROM中,MSQv2.1是最有效、最可靠的。除此以外,它还有望帮助指导偏头痛的临床治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.20
自引率
0.00%
发文量
73
审稿时长
6-12 weeks
期刊介绍: Current Neurology and Neuroscience Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of neurological disease and disorders. Presents the views of experts on current advances in neurology and neuroscience Gathers and synthesizes important recent papers on the topic Includes reviews of recently published clinical trials, valuable web sites, and commentaries from well-known figures in the field.
期刊最新文献
Correction to: Code-ICH: A New Paradigm for Emergency Interventionn. The Role of Mutant IDH Inhibitors in the Treatment of Glioma. Review on the Burden of Episodic Migraine and Utilization of Patient Reported Outcome Measures. Sedation Vacations in Neurocritical Care: Friend or Foe? Pharmacological Prevention of Postoperative Delirium in Adults: A Review of Recent Literature.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1